3 results
Sub-study APhase 1b:To assess the DLT rate and estimate the MTD of sasanlimab in combination with encorafenib and binimetinib to determine the RP2D for the combination. Phase 2:To assess the durable ORR of sasanlimab in combination with encorafenib…
The primary objective is to assess antibody responses against the SARS-CoV-2 vaccines in blood of individuals of 52-90 years of age at several timepoints post vaccination and post booster vaccinations, with respect to age, co-morbidities and frailty…
To evaluate the efficacy of rVWF (vonicog alfa) prophylaxis based on the annualized bleeding rate (ABR) of spontaneous (not related to trauma) bleeding episodes in adult and pediatric / adolescent subjects (aged 12 to <18 years) during the…